A remarkable presence of MicroPort® CRM at the European EHRA congress

Clamart, France, 13 May 2021– Microport^® CRM recently participated in the annual congress of the European Heart Rhythm Association (EHRA) from April 23 - 25. This year, more than 3,300 delegates registered to attend the virtual congress, bringing together scientists, healthcare professionals and other players involved in cardiac arrhythmia management from across the globe.

Through a virtual booth, MicroPort^® CRM used the congress as an opportunity to introduce their new line of pacemakers featuring Bluetooth connectivity, Alizea^TM, associated with the SmartView Connect^TM home monitor.

A highlight of this digital event was the 30-minute symposium, sponsored by MicroPort^® CRM, on ‘Promising advances in heart failure patient management,’which featured the below line-up:

• Prof. Frédéric Anselme (University Hospital of Rouen, France)​ presented “A new route to left ventricular pacing leveraging the Axone lead project”

• Prof. Martin Cowie (Imperial College London, United Kingdom)​ talked about “Emerging opportunities with digital health solutions to improve heart failure patient management”

• A live Q&A moderated by Prof. Francisco Leyva (Queen Elizabeth Hospital, Birmingham, United Kingdom)

About MicroPort^® CRM

MicroPort^® CRM, a subsidiary of MicroPort Scientific Corporation (stock code: 00853.HK), is a pioneering company in the field of Cardiac Rhythm Management (CRM), whose world headquarters are in Clamart, near Paris, France. Through our long-standing expertise in CRM, MicroPort^® CRM develops, manufactures and markets cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems, and ECG diagnostic solutions for the management of cardiac rhythm disorders and heart failure around the world. Our state-of-the-art products are manufactured in Clamart, France, Saluggia, Italy, and in Santo Domingo, Dominican Republic.

For more information, please refer to www.microport.com